SCHEMBL7829469

SCHEMBL7829469

Cc1nc(-c2ccc(-c3ccc(C(=O)n4ccc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 14/20 0.71
HTR1B P28222 12/20 0.71
HTR2A P28223 10/20 0.71
MEN1 O00255 5/20 0.71
MAPT P10636 5/20 0.71
KMT2A Q03164 5/20 0.71
TDP1 Q9NUW8 5/20 0.71
MAPK1 P28482 4/20 0.71
SLC6A4 P31645 4/20 0.71
TP53 P04637 3/20 0.71
CYP3A4 P08684 3/20 0.71
CYP2D6 P10635 3/20 0.71
HTR2C P28335 3/20 0.71
CYP2C9 P11712 2/20 0.71
TSHR P16473 2/20 0.71
CYP2C19 P33261 2/20 0.71
THPO P40225 2/20 0.71
CYP1A2 P05177 2/20 0.71
CHRM2 P08172 2/20 0.71
ADRA2A P08913 2/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7831541 0.95 HTR1D (0.65) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL7831413 0.87 HTR1D (0.56) HTR1DHTR1BHTR2AMEN1MAPT
Sb-224289 SCHEMBL29458144 0.83 HTR1D (1.00) HTR1DHTR1BHTR2AMEN1MAPT
Sb-224289 SCHEMBL7746188 0.83 HTR1D (1.00) HTR1DHTR1BHTR2AMEN1MAPT
Sb-224289 SCHEMBL29611979 0.82 MEN1 (1.00) HTR1DHTR1BHTR2AMEN1MAPT
Sb-224289 SCHEMBL6926494 0.82 MEN1 (1.00) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL9062600 0.82 MEN1 (0.49) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL7833082 0.82 HTR1D (0.91) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL9062597 0.81 HTR1D (0.48) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL6925631 0.81 HTR1D (0.90) HTR1DHTR1BHTR2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799226-B1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2001-02-07 EP claimed
US-5972951-A Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists SMITHKLINE BEECHAM PLC (GB) 1999-10-26 US claimed
WO-1996019477-A1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO claimed
EP-0799226-B1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2001-02-07 EP disclosed
US-5972951-A Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists SMITHKLINE BEECHAM PLC (GB) 1999-10-26 US disclosed
EP-0799226-A1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-10-08 EP disclosed
WO-1996019477-A1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO disclosed